Listed

Tonix Pharmaceuticals Holding Corp.

TNXPNasdaqCIK 1430306HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.5m, Q2 FY2026
Operating income−$42.5m, Q2 FY2026
Net income−$40.6m, Q2 FY2026
Tonix Pharmaceuticals Holding Corp., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.0Revenue, Q3 FY2023, three months to 2023-09-30$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure3.8Revenue, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure2.5Revenue, Q1 FY2024, three months to 2024-03-31$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure2.2Revenue, Q2 FY2024, three months to 2024-06-30$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure2.8Revenue, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure2.6Revenue, Q4 FY2024, three months to 2024-12-31$2.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure2.4Revenue, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure2.0Revenue, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure3.3Revenue, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure5.4Revenue, Q4 FY2025, three months to 2025-12-31$5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure6.9Revenue, Q1 FY2026, three months to 2026-03-31$6.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure13.5Revenue, Q2 FY2026, three months to 2026-06-30$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Cost of revenue$m2.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure2.4Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure1.7Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure3.4Cost of revenue, Q2 FY2024, three months to 2024-06-30$3.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure1.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure1.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure0.9Cost of revenue, Q1 FY2025, three months to 2025-03-31$943.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure3.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure1.4Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure1.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure1.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure0.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$703.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Research and development$m21.1Research and development, Q3 FY2023, three months to 2023-09-30$21.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure17.1Research and development, Q4 FY2023, three months to 2023-12-31$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure12.9Research and development, Q1 FY2024, three months to 2024-03-31$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure9.7Research and development, Q2 FY2024, three months to 2024-06-30$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure9.1Research and development, Q3 FY2024, three months to 2024-09-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure8.3Research and development, Q4 FY2024, three months to 2024-12-31$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure7.4Research and development, Q1 FY2025, three months to 2025-03-31$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure10.8Research and development, Q2 FY2025, three months to 2025-06-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure9.3Research and development, Q3 FY2025, three months to 2025-09-30$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure16.9Research and development, Q4 FY2025, three months to 2025-12-31$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure18.2Research and development, Q1 FY2026, three months to 2026-03-31$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure19.4Research and development, Q2 FY2026, three months to 2026-06-30$19.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Selling, general and administrative$m8.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$8.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure11.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$11.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure9.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$9.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure7.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$7.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure7.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$7.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure15.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure10.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$10.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure16.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure25.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$25.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure35.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$35.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure28.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$28.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure36.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$36.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Operating income$m(28.1)Operating income, Q3 FY2023, three months to 2023-09-30−$28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure(27.3)Operating income, Q4 FY2023, three months to 2023-12-31−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure(21.4)Operating income, Q1 FY2024, three months to 2024-03-31−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure(77.3)Operating income, Q2 FY2024, three months to 2024-06-30−$77.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure(15.6)Operating income, Q3 FY2024, three months to 2024-09-30−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(22.5)Operating income, Q4 FY2024, three months to 2024-12-31−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(16.1)Operating income, Q1 FY2025, three months to 2025-03-31−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(28.3)Operating income, Q2 FY2025, three months to 2025-06-30−$28.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(33.1)Operating income, Q3 FY2025, three months to 2025-09-30−$33.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(48.3)Operating income, Q4 FY2025, three months to 2025-12-31−$48.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(41.5)Operating income, Q1 FY2026, three months to 2026-03-31−$41.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(42.5)Operating income, Q2 FY2026, three months to 2026-06-30−$42.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported0.3Interest expense, Q3 FY2024, three months to 2024-09-30$301.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure0.3Interest expense, Q4 FY2024, three months to 2024-12-31$280.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m(28.0)Net income, Q3 FY2023, three months to 2023-09-30−$28.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure(27.3)Net income, Q4 FY2023, three months to 2023-12-31−$27.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Net income, Q1 FY2024, three months to 2024-03-31−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(78.8)Net income, Q2 FY2024, three months to 2024-06-30−$78.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(14.2)Net income, Q3 FY2024, three months to 2024-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(22.1)Net income, Q4 FY2024, three months to 2024-12-31−$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Net income, Q1 FY2025, three months to 2025-03-31−$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(28.3)Net income, Q2 FY2025, three months to 2025-06-30−$28.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(32.0)Net income, Q3 FY2025, three months to 2025-09-30−$32.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure(46.9)Net income, Q4 FY2025, three months to 2025-12-31−$46.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(40.2)Net income, Q1 FY2026, three months to 2026-03-31−$40.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(40.6)Net income, Q2 FY2026, three months to 2026-06-30−$40.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Diluted EPS$ per share(38.63)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$38.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figurenot reported(535.72)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$535.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure(1920.85)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1920.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure(22.68)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$22.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figurenot reported(2.84)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(3.86)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$3.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(3.59)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$3.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figurenot reported(2.93)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(2.44)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Basic EPS$ per share(38.63)Basic EPS, Q3 FY2023, three months to 2023-09-30−$38.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figurenot reported(535.72)Basic EPS, Q1 FY2024, three months to 2024-03-31−$535.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure(1920.85)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1920.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure(22.68)Basic EPS, Q3 FY2024, three months to 2024-09-30−$22.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figurenot reported(2.84)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(3.86)Basic EPS, Q2 FY2025, three months to 2025-06-30−$3.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure(3.59)Basic EPS, Q3 FY2025, three months to 2025-09-30−$3.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figurenot reported(2.93)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(2.44)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure

Balance sheet

Cash and equivalents$176.2m, Q2 FY2026
Long-term debt$4.7m, FY2024
Shareholders' equity$222.3m, Q2 FY2026
Tonix Pharmaceuticals Holding Corp., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.9Cash and equivalents, Q3 FY2023, at 2023-09-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure24.9Cash and equivalents, FY2023, at 2023-12-31$24.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure7.0Cash and equivalents, Q1 FY2024, at 2024-03-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure4.2Cash and equivalents, Q2 FY2024, at 2024-06-30$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure28.2Cash and equivalents, Q3 FY2024, at 2024-09-30$28.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure98.8Cash and equivalents, FY2024, at 2024-12-31$98.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure132Cash and equivalents, Q1 FY2025, at 2025-03-31$131.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure125Cash and equivalents, Q2 FY2025, at 2025-06-30$125.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure190Cash and equivalents, Q3 FY2025, at 2025-09-30$190.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure208Cash and equivalents, FY2025, at 2025-12-31$207.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure185Cash and equivalents, Q1 FY2026, at 2026-03-31$185.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure176Cash and equivalents, Q2 FY2026, at 2026-06-30$176.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Current assets$m31.3Current assets, Q3 FY2023, at 2023-09-30$31.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001839882-23-030328.Report this figure47.8Current assets, FY2023, at 2023-12-31$47.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure30.1Current assets, Q1 FY2024, at 2024-03-31$30.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure25.3Current assets, Q2 FY2024, at 2024-06-30$25.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure50.5Current assets, Q3 FY2024, at 2024-09-30$50.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure119Current assets, FY2024, at 2024-12-31$119.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure150Current assets, Q1 FY2025, at 2025-03-31$149.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure144Current assets, Q2 FY2025, at 2025-06-30$143.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure208Current assets, Q3 FY2025, at 2025-09-30$208.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure229Current assets, FY2025, at 2025-12-31$228.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure207Current assets, Q1 FY2026, at 2026-03-31$207.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure203Current assets, Q2 FY2026, at 2026-06-30$203.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Total assets$m139Total assets, Q3 FY2023, at 2023-09-30$139.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001839882-23-030328.Report this figure154Total assets, FY2023, at 2023-12-31$154.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure135Total assets, Q1 FY2024, at 2024-03-31$135.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure70.3Total assets, Q2 FY2024, at 2024-06-30$70.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure95.0Total assets, Q3 FY2024, at 2024-09-30$95.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure163Total assets, FY2024, at 2024-12-31$162.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure193Total assets, Q1 FY2025, at 2025-03-31$192.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure187Total assets, Q2 FY2025, at 2025-06-30$187.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure252Total assets, Q3 FY2025, at 2025-09-30$252.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure277Total assets, FY2025, at 2025-12-31$277.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure258Total assets, Q1 FY2026, at 2026-03-31$257.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure254Total assets, Q2 FY2026, at 2026-06-30$254.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Current liabilities$m17.7Current liabilities, Q3 FY2023, at 2023-09-30$17.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001839882-23-030328.Report this figure18.9Current liabilities, FY2023, at 2023-12-31$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure20.5Current liabilities, Q1 FY2024, at 2024-03-31$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure22.0Current liabilities, Q2 FY2024, at 2024-06-30$22.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure15.2Current liabilities, Q3 FY2024, at 2024-09-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure18.3Current liabilities, FY2024, at 2024-12-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure12.1Current liabilities, Q1 FY2025, at 2025-03-31$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure19.1Current liabilities, Q2 FY2025, at 2025-06-30$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure21.0Current liabilities, Q3 FY2025, at 2025-09-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure30.8Current liabilities, FY2025, at 2025-12-31$30.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure29.6Current liabilities, Q1 FY2026, at 2026-03-31$29.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure30.8Current liabilities, Q2 FY2026, at 2026-06-30$30.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Total liabilities$m18.4Total liabilities, Q3 FY2023, at 2023-09-30$18.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001839882-23-030328.Report this figure48.9Total liabilities, FY2023, at 2023-12-31$48.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure27.2Total liabilities, Q1 FY2024, at 2024-03-31$27.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure28.2Total liabilities, Q2 FY2024, at 2024-06-30$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure20.8Total liabilities, Q3 FY2024, at 2024-09-30$20.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure23.3Total liabilities, FY2024, at 2024-12-31$23.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure12.5Total liabilities, Q1 FY2025, at 2025-03-31$12.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure19.4Total liabilities, Q2 FY2025, at 2025-06-30$19.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure21.3Total liabilities, Q3 FY2025, at 2025-09-30$21.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure32.0Total liabilities, FY2025, at 2025-12-31$32.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure30.8Total liabilities, Q1 FY2026, at 2026-03-31$30.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure31.8Total liabilities, Q2 FY2026, at 2026-06-30$31.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure
Long-term debt$mnot reported6.6Long-term debt, FY2023, at 2023-12-31$6.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure6.2Long-term debt, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure5.7Long-term debt, Q2 FY2024, at 2024-06-30$5.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure5.2Long-term debt, Q3 FY2024, at 2024-09-30$5.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure4.7Long-term debt, FY2024, at 2024-12-31$4.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reported2.4Current portion of debt, FY2023, at 2023-12-31$2.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-18, accession 0001999371-25-002786.Report this figure2.8Current portion of debt, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure2.8Current portion of debt, Q2 FY2024, at 2024-06-30$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure2.8Current portion of debt, Q3 FY2024, at 2024-09-30$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure2.8Current portion of debt, FY2024, at 2024-12-31$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m121Shareholders' equity, Q3 FY2023, at 2023-09-30$120.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure106Shareholders' equity, FY2023, at 2023-12-31$105.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001999371-26-005730.Report this figure108Shareholders' equity, Q1 FY2024, at 2024-03-31$108.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure42.1Shareholders' equity, Q2 FY2024, at 2024-06-30$42.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure74.2Shareholders' equity, Q3 FY2024, at 2024-09-30$74.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure140Shareholders' equity, FY2024, at 2024-12-31$139.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure180Shareholders' equity, Q1 FY2025, at 2025-03-31$180.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure168Shareholders' equity, Q2 FY2025, at 2025-06-30$168.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure231Shareholders' equity, Q3 FY2025, at 2025-09-30$231.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure245Shareholders' equity, FY2025, at 2025-12-31$245.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure227Shareholders' equity, Q1 FY2026, at 2026-03-31$227.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure222Shareholders' equity, Q2 FY2026, at 2026-06-30$222.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure

Cash flow

Operating cash flow−$42.2m, Q2 FY2026
Capital expenditure$587.0k, Q2 FY2026
Share repurchases$7.8m, Q4 FY2025
Tonix Pharmaceuticals Holding Corp., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(23.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001999371-24-014569. Derived: 9-month figure less the 6-month figure.Report this figure(22.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure(9.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001999371-25-011050. Derived: 6-month figure less the 3-month figure.Report this figure(18.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001999371-25-017370. Derived: 9-month figure less the 6-month figure.Report this figure(14.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(14.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001999371-26-017452. Derived: 6-month figure less the 3-month figure.Report this figure(28.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$28.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001999371-25-017370. Derived: 9-month figure less the 6-month figure.Report this figure(39.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$39.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure(42.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$42.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure(42.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$42.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001999371-26-017452. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001999371-24-014569. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$438.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001999371-25-011050. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001999371-25-017370. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$527.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001999371-26-017452. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$962.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001999371-25-017370. Derived: 9-month figure less the 6-month figure.Report this figure1.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figure1.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure0.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$587.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001999371-26-017452. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-12, accession 0001999371-24-014569. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-18, accession 0001999371-25-002786. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported3.0Share repurchases, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure2.9Share repurchases, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-10, accession 0001999371-25-017370. Derived: 9-month figure less the 6-month figure.Report this figure7.8Share repurchases, Q4 FY2025, three months to 2025-12-31$7.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-12, accession 0001999371-26-005730. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)16.64m, Q2 FY2026
Tonix Pharmaceuticals Holding Corp., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares6.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-306,843,099 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001839882-23-030328.Report this figure10.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3110,268,500 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001999371-24-005989.Report this figure0.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30576,047 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-16, accession 0001999371-24-010281.Report this figure0.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30724,190 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001999371-24-014569.Report this figure0.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,886 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001999371-25-005875.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3041,011 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001999371-25-011050.Report this figure0.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30626,669 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure5.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-315,927,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure7.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-307,327,257 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure8.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-308,922,792 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001999371-25-017370.Report this figure13.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,707,104 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001999371-26-010486.Report this figure16.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3016,635,254 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure

Shares outstanding: 17.15mShares outstanding, period not labelled, at 2026-08-0717,151,024 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001999371-26-017452.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.